aptaTargets is a clinical-stage biopharmaceutical company focused on developing therapeutic applications based on aptamer technology
aptaTargets is a clinical-stage biopharmaceutical company focused on developing therapeutic applications based on aptamer technology. Their lead candidate, ApTOLL, is a neuroprotective drug for acute ischemic stroke, targeting inflammation in the acute phase.